Latest Institutional Sells of Acrivon Therapeutics, Inc. (ACRV)
This list provides information on the latest institutional transactions involving Acrivon Therapeutics, Inc. (ACRV) stock that were sells. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the sale has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 13, 2025
Q2 2025
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-269K- 59.77% |
N/A
|
181K
$0
|
|
Aug 14, 2025
Q2 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-165K- 71.13% |
N/A
|
67.1K
$0
|
|
Aug 08, 2025
Q2 2025
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-142K- 46.31% |
N/A
|
164K
$0
|
|
Aug 11, 2025
Q2 2025
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-81.5K- 12.08% |
N/A
|
593K
$0
|
|
Aug 13, 2025
Q2 2025
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-62.2K- 57.1% |
N/A
|
46.8K
$0
|
|
Aug 14, 2025
Q2 2025
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-55K- 70.6% |
N/A
|
22.9K
$0
|
|
Aug 12, 2025
Q2 2025
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-47.7K- 42.84% |
N/A
|
63.6K
$0
|
|
Aug 12, 2025
Q2 2025
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-22K- 49.71% |
N/A
|
22.2K
$0
|
|
Aug 14, 2025
Q2 2025
|
Ubs Group Ag
|
SELL
|
- |
-12.4K- 96.47% |
N/A
|
455
$0
|
|
Aug 13, 2025
Q2 2025
|
Barclays PLC
London, X0 |
SELL
|
- |
-11.8K- 36.01% |
N/A
|
20.9K
$0
|
|
Aug 14, 2025
Q2 2025
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-7.08K- 25.57% |
N/A
|
20.6K
$0
|
|
Aug 14, 2025
Q2 2025
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-6.95K- 98.01% |
N/A
|
141
$0
|
|
Aug 14, 2025
Q2 2025
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-818- 96.35% |
N/A
|
31
$0
|
|
Jul 31, 2025
Q2 2025
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-375- 39.1% |
N/A
|
584
$0
|
|
Q1 2025 | |||||||
May 15, 2025
Q1 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-224K- 10.57% |
N/A
|
1.9M
$0
|
|
May 15, 2025
Q1 2025
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-87.2K- 84.85% |
N/A
|
15.6K
$0
|
|
May 15, 2025
Q1 2025
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-30.1K- 56.87% |
N/A
|
22.8K
$0
|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-17.3K- 67.15% |
N/A
|
8.48K
$0
|
|
Apr 29, 2025
Q1 2025
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-357- 5.41% |
N/A
|
6.25K
$0
|
|
Apr 14, 2025
Q1 2025
|
Gamma Investing LLC
Foster City, CA |
SELL
|
- |
-296- 50.77% |
N/A
|
287
$0
|
|
May 13, 2025
Q1 2025
|
American Century Companies Inc
Kansas City, MO |
SELL
|
- |
-207- 1.18% |
N/A
|
17.4K
$0
|
|
May 13, 2025
Q1 2025
|
Sterling Capital Management LLC
Charlotte, NC |
SELL
|
- |
-203- 50.62% |
N/A
|
198
$0
|
|
Q4 2024 | |||||||
Feb 12, 2025
Q4 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-13.5K- 44.47% |
N/A
|
16.9K
$0
|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-12.4K- 48.01% |
N/A
|
13.4K
$0
|
|
Q3 2024 | |||||||
Nov 14, 2024
Q3 2024
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-8.94K- 7.36% |
N/A
|
112K
$0
|
|
Q2 2024 | |||||||
Aug 14, 2024
Q2 2024
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-371- 30.24% |
N/A
|
856
$0
|
|
Q1 2024 | |||||||
Apr 23, 2024
Q1 2024
|
Amalgamated Bank
New York, NY |
SELL
|
- |
-853- 69.29% |
N/A
|
378
$0
|
|
Apr 25, 2024
Q1 2024
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-382- 1.54% |
N/A
|
24.4K
$0
|
|
Q4 2023 | |||||||
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-14.8K- 31.68% |
N/A
|
31.9K
$0
|
|
Q3 2023 | |||||||
Nov 14, 2023
Q3 2023
|
Nea Management Company, LLC
Timonium, MD |
SELL
|
- |
-51.4K- 10.68% |
N/A
|
430K
$0
|
|
Q2 2023 | |||||||
Aug 14, 2023
Q2 2023
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-85- 9.2% |
N/A
|
839
$0
|